Goss, G. D., O'Callaghan, C., Lorimer, I., Tsao, M., Masters, G. A., Jett, J., . . . Shepherd, F. A. (2013). Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study. American Society of Clinical Oncology.
استشهاد بنمط شيكاغوGoss, Glenwood D., et al. Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study. American Society of Clinical Oncology, 2013.
MLA استشهادGoss, Glenwood D., et al. Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study. American Society of Clinical Oncology, 2013.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.